EcoDrugPlus

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSJJAG00000015293
Gene Symbol: TRPA1
3 Cross references
226 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSJJAG00000021473
Gene Symbol: TRPM8
3 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSJJAG00000010388
Gene Symbol: TRPV1
3 Cross references
134 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSJJAG00000021263
Gene Symbol: TSPO
3 Cross references
126 Possible Orthologues:

Transthyretin

Ensembl ID : ENSJJAG00000013612
Gene Symbol: TTR
3 Cross references
164 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSJJAG00000023739
Gene Symbol: TPH1
3 Cross references
255 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSJJAG00000011005
Gene Symbol: TUBA4A
3 Cross references
224 Possible Orthologues:

Tubulin Alpha-1b Chain

Ensembl ID : ENSJJAG00000003271
Gene Symbol: LOC101617653
3 Cross references
200 Possible Orthologues:

Tubulin Alpha-1c Chain

Ensembl ID : ENSJJAG00000010823
Gene Symbol: LOC101593357
3 Cross references
119 Possible Orthologues:

Tubulin Alpha-3 Chain

Ensembl ID : ENSJJAG00000017028
Gene Symbol: LOC101606113
3 Cross references
210 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSJJAG00000019495
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 2a Class Iia

Ensembl ID : ENSJJAG00000011739
Gene Symbol: TUBB2A
3 Cross references
181 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).